Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 56

1.

The Utility of Exercise Testing in Patients with Lung Cancer.

Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M.

J Thorac Oncol. 2016 May 5. pii: S1556-0864(16)30402-6. doi: 10.1016/j.jtho.2016.04.021. [Epub ahead of print] Review.

PMID:
27156441
2.

The IASLC Lung Cancer Staging Project: Background Data and Proposed Criteria to Distinguish Separate Primary Lung Cancers from Metastatic Foci in Patients with Two Lung Tumors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Franklin WA, Nicholson AG, Girard N, Arenberg DA, Travis WD, Mazzone PJ, Marom EM, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):651-65. doi: 10.1016/j.jtho.2016.01.025. Epub 2016 Mar 2.

PMID:
26944304
3.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Classification of Lung Cancer with Separate Tumor Nodules in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.

Detterbeck FC, Bolejack V, Arenberg DA, Crowley J, Donington JS, Franklin WA, Girard N, Marom EM, Mazzone PJ, Nicholson AG, Rusch VW, Tanoue LT, Travis WD, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):681-92. doi: 10.1016/j.jtho.2015.12.114. Epub 2016 Mar 3.

PMID:
26940530
4.

The IASLC Lung Cancer Staging Project: Summary of Proposals for Revisions of the Classification of Lung Cancers with Multiple Pulmonary Sites of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Nicholson AG, Franklin WA, Marom EM, Travis WD, Girard N, Arenberg DA, Bolejack V, Donington JS, Mazzone PJ, Tanoue LT, Rusch VW, Crowley J, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup; Participating Institutions.

J Thorac Oncol. 2016 May;11(5):639-50. doi: 10.1016/j.jtho.2016.01.024. Epub 2016 Mar 3.

PMID:
26940528
5.

The IASLC Lung Cancer Staging Project: Background Data and Proposals for the Application of TNM Staging Rules to Lung Cancer Presenting as Multiple Nodules with Ground Glass or Lepidic Features or a Pneumonic Type of Involvement in the Forthcoming Eighth Edition of the TNM Classification.

Detterbeck FC, Marom EM, Arenberg DA, Franklin WA, Nicholson AG, Travis WD, Girard N, Mazzone PJ, Donington JS, Tanoue LT, Rusch VW, Asamura H, Rami-Porta R; IASLC Staging and Prognostic Factors Committee; Advisory Boards; Multiple Pulmonary Sites Workgroup.

J Thorac Oncol. 2016 May;11(5):666-80. doi: 10.1016/j.jtho.2015.12.113. Epub 2016 Mar 3.

PMID:
26940527
6.

Lung cancer risk test trial: study design, participant baseline characteristics, bronchoscopy safety, and establishment of a biospecimen repository.

Crawford EL, Levin A, Safi F, Lu M, Baugh A, Zhang X, Yeo J, Khuder SA, Boulos AM, Nana-Sinkam P, Massion PP, Arenberg DA, Midthun D, Mazzone PJ, Nathan SD, Wainz R, Silvestri G, Tita J, Willey JC.

BMC Pulm Med. 2016 Jan 22;16:16. doi: 10.1186/s12890-016-0178-4.

7.

Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.

Mazzone PJ, Wang XF, Beukemann M, Zhang Q, Seeley M, Mohney R, Holt T, Pappan KL.

J Thorac Oncol. 2016 Jan;11(1):72-8. doi: 10.1016/j.jtho.2015.09.002.

PMID:
26762741
8.

Accuracy of volatile urine biomarkers for the detection and characterization of lung cancer.

Mazzone PJ, Wang XF, Lim S, Choi H, Jett J, Vachani A, Zhang Q, Beukemann M, Seeley M, Martino R, Rhodes P.

BMC Cancer. 2015 Dec 23;15:1001. doi: 10.1186/s12885-015-1996-0.

9.

An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice.

Wiener RS, Gould MK, Arenberg DA, Au DH, Fennig K, Lamb CR, Mazzone PJ, Midthun DE, Napoli M, Ost DE, Powell CA, Rivera MP, Slatore CG, Tanner NT, Vachani A, Wisnivesky JP, Yoon SH; ATS/ACCP Committee on Low-Dose CT Lung Cancer Screening in Clinical Practice.

Am J Respir Crit Care Med. 2015 Oct 1;192(7):881-91. doi: 10.1164/rccm.201508-1671ST.

PMID:
26426785
10.

Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk.

Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ.

Ann Thorac Surg. 2015 Nov;100(5):1954-62. doi: 10.1016/j.athoracsur.2015.06.085. Epub 2015 Sep 26. Review.

PMID:
26410158
11.

Progress in the development of volatile exhaled breath signatures of lung cancer.

Mazzone PJ, Wang XF, Lim S, Jett J, Choi H, Zhang Q, Beukemann M, Seeley M, Martino R, Rhodes P.

Ann Am Thorac Soc. 2015 May;12(5):752-7. doi: 10.1513/AnnalsATS.201411-540OC.

12.

Cystic lung disease: systematic, stepwise diagnosis.

Ha D, Yadav R, Mazzone PJ.

Cleve Clin J Med. 2015 Feb;82(2):115-27. doi: 10.3949/ccjm.82a.14020. Review.

13.

Validation of a multiprotein plasma classifier to identify benign lung nodules.

Vachani A, Pass HI, Rom WN, Midthun DE, Edell ES, Laviolette M, Li XJ, Fong PY, Hunsucker SW, Hayward C, Mazzone PJ, Madtes DK, Miller YE, Walker MG, Shi J, Kearney P, Fang KC, Massion PP.

J Thorac Oncol. 2015 Apr;10(4):629-37. doi: 10.1097/JTO.0000000000000447.

14.

Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery.

Ha D, Choi H, Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ.

J Thorac Cardiovasc Surg. 2015 Apr;149(4):1168-73.e3. doi: 10.1016/j.jtcvs.2014.11.037. Epub 2014 Nov 21.

PMID:
25583106
15.

Survival in patients with metachronous second primary lung cancer.

Ha D, Choi H, Chevalier C, Zell K, Wang XF, Mazzone PJ.

Ann Am Thorac Soc. 2015 Jan;12(1):79-84. doi: 10.1513/AnnalsATS.201406-261OC.

PMID:
25494009
16.

Serum free fatty acid biomarkers of lung cancer.

Liu J, Mazzone PJ, Cata JP, Kurz A, Bauer M, Mascha EJ, Sessler DI.

Chest. 2014 Sep;146(3):670-9. doi: 10.1378/chest.13-2568.

PMID:
24743744
17.

Quality indicators for the evaluation of patients with lung cancer.

Mazzone PJ, Vachani A, Chang A, Detterbeck F, Cooke D, Howington J, Dodi A, Arenberg D.

Chest. 2014 Sep;146(3):659-69. doi: 10.1378/chest.13-2900.

18.

Quality of life and healthcare use in a randomized controlled lung cancer screening study.

Mazzone PJ, Obuchowski N, Fu AZ, Phillips M, Meziane M.

Ann Am Thorac Soc. 2013 Aug;10(4):324-9. doi: 10.1513/AnnalsATS.201301-007OC.

PMID:
23952850
19.

An attempt to reach the galaxy of the pulmonary nodules.

Mehta AC, Mazzone PJ.

Am J Respir Crit Care Med. 2013 Aug 1;188(3):264-5. doi: 10.1164/rccm.201305-0982ED. No abstract available.

PMID:
23905518
20.

Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Gould MK, Donington J, Lynch WR, Mazzone PJ, Midthun DE, Naidich DP, Wiener RS.

Chest. 2013 May;143(5 Suppl):e93S-120S. doi: 10.1378/chest.12-2351. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk